Efgartigimod led to statistically significant improvement in key symptoms of ocular myasthenia gravis compared with placebo in a phase 3 trial.

Feedback is excited to learn that University of Maryland researchers are measuring farts in a bid to build a Human Flatus ...

Driving global innovation through precision sensing technology, intelligent data integration, and sustainable water ...

Finnish Customs seized 2,574 kilos of drugs in 2025, including record cocaine volumes and new synthetic opioids. Authorities also reported rises in drug medicines, doping offences, weapons and ...

We are very pleased to have aligned with the FDA on the path forward for our MAGNITUDE clinical trial, with measures designed to further enhance patient safety and allow us to continue to investigate ...

Anifrolumab yielded positive outcomes, including remission in 26% of patients, at 6 months across a real-word, multicenter cohort of patients with systemic lupus erythematosus, according to data ...

Lynk Pharmaceuticals Co., Ltd. ("Lynk Pharmaceuticals"), a clinical-stage innovative drug development company focused on therapies for immune and inflammatory diseases, today announced positive ...

. Globally, the V-Class is offered with two wheelbase choices - Long at 3,200mm and Extra Long measuring 3,430mm. The Indian market gets extra long variant with the AMG line exterior package. Buyers ...

Orforglipron, which could be approved for obesity next quarter, proved superior at cutting blood sugar and body weight — but ...

Chery Australia says it has 'strong interest' in Corolla-sized electric hatchback that could rival BYD, MG and GWM in the ...

PYRUKYND is also approved for adults with PK deficiency in the U.S. and Europe, and a marketing application for PYRUKYND in thalassemia is currently under review by the European Commission. In the U.S ...

“With the brepocitinib CS program now moving into Phase 3 alongside the dermatomyositis and non-infectious uveitis programs, Priovant continues to advance our goal of developing brepocitinib as a ...